标题
Epigenetics and Oncology
作者
关键词
-
出版物
PHARMACOTHERAPY
Volume 34, Issue 5, Pages 495-505
出版商
Wiley
发表日期
2014-03-11
DOI
10.1002/phar.1408
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Circulating Methylated Septin 9 Nucleic Acid in the Plasma of Patients with Gastrointestinal Cancer in the Stomach and Colon
- (2014) Hye Seung Lee et al. Translational Oncology
- Cancer screening in the United States, 2013
- (2013) Robert A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 5-hydroxymethylcytosine and its potential roles in development and cancer
- (2013) Gerd P Pfeifer et al. Epigenetics & Chromatin
- Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML
- (2012) Alyson A. Lokken et al. CANCER CELL
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk
- (2012) K. Brennan et al. CANCER RESEARCH
- Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation
- (2012) Yotaro Kudo et al. CANCER SCIENCE
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Multiple roles of class I HDACs in proliferation, differentiation, and development
- (2012) Nina Reichert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies
- (2012) Jacques Fahy et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Low values of 5-hydroxymethylcytosine (5hmC), the “sixth base,” are associated with anaplasia in human brain tumors
- (2012) Theo F.J. Kraus et al. INTERNATIONAL JOURNAL OF CANCER
- Histone Deacetylase Inhibitors in Non–Small-Cell Lung Cancer
- (2012) Samir Witta Journal of Thoracic Oncology
- Genetic heterogeneity and cancer drug resistance
- (2012) Nicholas C Turner et al. LANCET ONCOLOGY
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
- (2012) H Yang et al. ONCOGENE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection
- (2012) Leander Van Neste et al. BMC Urology
- Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide
- (2011) J Chang et al. BRITISH JOURNAL OF CANCER
- 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
- (2011) S.-G. Jin et al. CANCER RESEARCH
- Romidepsin: a novel histone deacetylase inhibitor for cancer
- (2011) Erin M Bertino et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
- (2011) K Ted Thurn et al. Future Oncology
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population
- (2011) Susanna H Hutajulu et al. Molecular Cancer
- Epigenetics and colorectal cancer
- (2011) Victoria Valinluck Lao et al. Nature Reviews Gastroenterology & Hepatology
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- New Ways to Use DNA Methyltransferase Inhibitors for the Treatment of Myelodysplastic Syndrome
- (2011) S. D. Gore Hematology-American Society of Hematology Education Program
- Advancing breast cancer therapy by translational research: highlights of the Improving Care and Knowledge through Translational Research (IMPAKT) breast cancer conference
- (2011) Gordon Mallarkey et al. Therapeutic Advances in Medical Oncology
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- Drugging Drug Resistance
- (2010) Jan-Hermen Dannenberg et al. CELL
- Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704
- (2010) Ananya Manuyakorn et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
- (2010) S. L. Holbeck et al. MOLECULAR CANCER THERAPEUTICS
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Epigenetic modifications and human disease
- (2010) Anna Portela et al. NATURE BIOTECHNOLOGY
- Targeting histone deacetylases: development of vorinostat for the treatment of cancer
- (2010) Victoria M Richon Epigenomics
- Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
- (2009) T. E. Fandy et al. BLOOD
- Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas
- (2009) D. J. Stewart et al. CLINICAL CANCER RESEARCH
- Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial
- (2009) David P. Steensma et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines
- (2009) Wei Zhang et al. Journal of Thoracic Oncology
- Recent Advances in the Detection of Prostate Cancer Using Epigenetic Markers in Commonly Collected Laboratory Samples
- (2009) Adam Maxwell et al. Labmedicine
- Epigenetic side-effects of common pharmaceuticals: A potential new field in medicine and pharmacology
- (2009) Antonei B. Csoka et al. MEDICAL HYPOTHESES
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
- (2009) Rafael A Irizarry et al. NATURE GENETICS
- Genetic and Epigenetic Marker-Based DNA Test of Stool Is a Promising Approach for Colorectal Cancer Screening
- (2009) Sung Whan An et al. YONSEI MEDICAL JOURNAL
- Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
- (2008) Y. Jiang et al. BLOOD
- Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers
- (2008) F. Braiteh et al. CLINICAL CANCER RESEARCH
- Azacitidine and the beginnings of therapeutic epigenetic modulation
- (2008) Kristen O'Dwyer et al. EXPERT OPINION ON PHARMACOTHERAPY
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes
- (2008) Elizabeth A. Griffiths et al. SEMINARS IN HEMATOLOGY
- Cancer Epigenetics: Modifications, Screening, and Therapy
- (2007) Gal-Yam Einav Nili et al. Annual Review of Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More